MediGuide, a subsidiary of Elbit Systems, has allied with Boston Scientific to develop and commercialize technology platforms in the fields of 3D intravascular imaging and intrabody navigation. The agreement includes an equity investment in MediGuide by
MediGuide, a subsidiary of Elbit Systems, has allied with Boston Scientific to develop and commercialize technology platforms in the fields of 3D intravascular imaging and intrabody navigation. The agreement includes an equity investment in MediGuide by Boston Scientific, codevelopment responsibilities for integrating Boston Scientific's device platforms with MediGuide's proprietary guidance system, exclusive global distribution, and an option for Boston Scientific to acquire MediGuide at a future time.
The cornerstone of the alliance is an advanced navigation system developed by the Arlington, VA, company. The Medical Positioning System (MPS) enables real-time tracking of miniature sensors integrated into therapeutic and diagnostic medical devices. These devices register their exact location and orientation utilizing advanced diagnostic systems such as Boston Scientific's intravascular ultrasound system, as well as other diagnostic systems including x-ray angiography, MR, and CT. Boston Scientific and MediGuide plan to integrate the MPS with Boston Scientific's IVUS.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.